Summary
- Current Price
- As of today, CHRS price is $1.71, up +4.91% on
- Current Price All-Time High
- CHRS price is currently -95.51% below its historical high of $38.10 set on
- Market Cap
- CHRS current market cap is $207M, up +62.14% over the past 365 days
- PE Ratio
- CHRS PE ratio is unknown
- Revenue
- CHRS current annual revenue is $266.96M, up +3.78% year-over-year
- Next Earnings
- The next earnings release for CHRS is on
Profile
| Metric | Value |
|---|---|
| Full Name | Coherus Oncology, Inc. |
| Ticker | NASDAQ: CHRS |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | coherus.com |
| Employees | 221 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| $1.71 | ||
| Price, 1D Change | +4.91% | |
| $207M | ||
| - | ||
| - | ||
| 1.35 | ||
| $267M | ||
| Revenue, 1Y Change | +3.78% | |
| $0.25 | ||
| EPS, 1Y Change | +109.82% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| $0.25 | ||
| EPS Estimate | -$1.33 | |
| EPS Est. Change | -635.86% | |
| $266.96M | ||
| Revenue Estimate | $43.47M | |
| Revenue Est. Change | -83.72% | |
| $1.71 | ||
| Price Target | - | $6.50 |
| Price Tgt. Change | - | +280.12% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$1.71 | -$2.53 | -47.74% | |
| -$0.86 | $0.25 | +128.93% | |
| -$1.33 | N/A | -635.86% | |
| -$0.49 | N/A | -297.42% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $262.38M | $257.24M | -1.96% | |
| $255.58M | $266.96M | +4.45% | |
| $43.47M | N/A | -83.72% | |
| $95.15M | N/A | -64.36% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| +55.45% | ||
| -78.08% | ||
| +62.14% | ||
| -66.39% | ||
| +3.78% | ||
| -18.25% | ||
| +109.82% | ||
| +106.52% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| $1.71 | ||
| $1.29 | ||
| SMA 200 vs Price | -24.85% | |
| $1.68 | ||
| SMA 50 vs Price | -1.67% | |
| 1.35 | ||
| $0.18 | ||
| 44.15 | ||
| 111.05% | ||
| 89.48% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $266.96M | ||
| $0.25 | ||
| $144.13M | ||
| 53.99% | ||
| -$111.67M | ||
| -39.29% | ||
| $28.51M | ||
| 10.68% | ||
| $55.67M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.00 | ||
| 2.13 | ||
| 1.70 | ||
| 2.05 | ||
| 4 | ||
| -3.08 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| 2.47 | ||
| 2.35 | ||
| -0.42 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| -$131.99M | ||
| $125.99M | ||
| $454.85M | ||
| $351.18M | ||
| $586.84M | ||
| $164.87M | ||
| $298.65M | ||
| $2.84M | ||
| $28.46M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $378.63M | ||
| $261.07M | ||
| $122.83M | ||
| $167.74M | ||
| $5.28M | ||
| $27.16M | ||
| $0.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$20.44M | ||
| $230.32M | ||
| -$186.97M | ||
| $0.00 | ||
| -$20.44M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Oppenheimer | ||
| Maxim Group | → | |
| HC Wainwright & Co. | → | |
| UBS | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| Baird | → | |
| HC Wainwright & Co. | → | |
| Baird | → |
Analyst sentiment
Institutional ownership
Screeners with CHRS
FAQ
What is the ticker symbol for Coherus Oncology, Inc.?
The ticker symbol for Coherus Oncology, Inc. is NASDAQ:CHRS
Does Coherus Oncology, Inc. pay dividends?
No, Coherus Oncology, Inc. does not pay dividends
What sector is Coherus Oncology, Inc. in?
Coherus Oncology, Inc. is in the Healthcare sector
What industry is Coherus Oncology, Inc. in?
Coherus Oncology, Inc. is in the Biotechnology industry
What country is Coherus Oncology, Inc. based in?
Coherus Oncology, Inc. is headquartered in United States
When did Coherus Oncology, Inc. go public?
Coherus Oncology, Inc. initial public offering (IPO) was on November 6, 2014
Is Coherus Oncology, Inc. in the S&P 500?
No, Coherus Oncology, Inc. is not included in the S&P 500 index
Is Coherus Oncology, Inc. in the NASDAQ 100?
No, Coherus Oncology, Inc. is not included in the NASDAQ 100 index
Is Coherus Oncology, Inc. in the Dow Jones?
No, Coherus Oncology, Inc. is not included in the Dow Jones index
When was Coherus Oncology, Inc. last earnings report?
Coherus Oncology, Inc.'s most recent earnings report was on November 6, 2025
When does Coherus Oncology, Inc. report earnings?
The next expected earnings date for Coherus Oncology, Inc. is March 10, 2026
Data Sources & References
- CHRS Official Website www.coherus.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1512762/000110465925107852/0001104659-25-107852-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1512762/000155837025003126/0001558370-25-003126-index.htm
- CHRS Profile on Yahoo Finance finance.yahoo.com/quote/CHRS
- CHRS Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/chrs